BioAtla BCAB Earnings Call Transcripts

OTC BCAB
$1.80 -0.01 (-0.55%)
At close: Nov 10, 2026 · 4:00 PM EST
1 earnings call on file for BioAtla, Q3 2025. Each transcript opens in a new tab.
Latest earnings call

BioAtla Q3 2025 Earnings Call

Nov 13, 2025 2,450 words · 11 min read
  • Dr. Jay M. ShortChairman, Chief Executive Officer, and Co-founder
  • Dr. Eric L. SieversChief Medical Officer
  • Sheri LydickChief Commercial Officer
  • Richard A. WaldronChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

BioAtla Earnings Call Transcripts

Calls1
LatestNov 13, 2025
SinceQ3 2025

Fiscal 2025

All 1 BioAtla transcript Register to get access to BioAtla’s earnings call transcripts.